Stonepine Capital Management, LLC has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $126 Billion distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Evolus, Inc. with a value of $37.4B, Adma Biologics, Inc. with a value of $22.6B, Alimera Sciences Inc with a value of $15.8B, Galapagos Nv with a value of $12.7B, and Revance Therapeutics, Inc. with a value of $9.72B.

Examining the 13F form we can see an decrease of $105B in the current position value, from $231B to 126B.

Stonepine Capital Management, LLC is based out at Bend, OR

Below you can find more details about Stonepine Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $126 Billion
Healthcare: $107 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $126 Billion
  • Prior Value $231 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 14, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 8 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.